FGH Biotech, Inc. — Form D
FGH Biotech, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-06. The offering totals $2.5M. Industry: Pharmaceuticals.
Offering
- Filed: 2015-11-06
- Form: D
- Accession: 0001657572-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Remaining: $2.5M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-250812
Issuer
- Name: FGH Biotech, Inc.
- CIK: 0001657572
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 414 THAMER CIRCLE, HOUSTON, TX, 77024
- Phone: 7134654028
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Lufti J Abu-Elheiga | Executive Officer | Houston, TX |
| Joe Wakil | Director | Houston, TX |
| Joe Wakil | Executive Officer | Houston, TX |
| Salih J Wakil | Director | Houston, TX |
| Salih J Wakil | Executive Officer | Houston, TX |
| Adam J Kuspa | Director | Houston, TX |
Other filings by this issuer (2)
More